Quest Diagnostics Investments, Inc., based in Secaucus, NJ, specializes in advanced diagnostic testing and laboratory services. The company focuses on mass spectrometry technologies, which are pivotal in cancer detection, vitamin analysis, hormone measurement, and genetic testing. Their expertise extends to nucleic acid analysis, tumor mutations, and the assessment of cell-free DNA, positioning them as a leader in the diagnostic field and contributing significantly to personalized medicine and patient care.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

499 Patents

#1 in Secaucus, NJ

#53 in New Jersey

#975 in US

#1,941 in the World

Secaucus, NJ, United States of America

Quest Diagnostics Investments, Inc.

Forward Citations = 2,057

239 inventors:

Nigel J Clarke (115 out of 118 patents)

Richard E Reitz (89 out of 91 patents)

Maher Albitar (39 out of 51 patents)

4. Heather R Sanders (39 out of 39 patents)

5. Brett Holmquist (38 out of 39 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Quest Diagnostics Investments, Inc.. Retrieved from https://idiyas.com/company/quest-diagnostics-investments

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

7 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

115 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]